International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Russia · Delayed Price · Currency is RUB

672.00

-1.50 (-0.22%)

At close: Jul 8, 2022

MOEX:GEMA Income Statement

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	376.74	348.6	283.51	254.68	265.89
Revenue Growth (YoY)	8.07%	22.96%	11.32%	-4.22%	9.59%
Cost of Revenue	72.7	58.72	47.95	51.67	61.82
Gross Profit	304.04	289.89	235.56	203	204.07
Selling, General & Admin	122.24	111.74	86.2	64.41	65.52
Operating Expenses	122.24	111.74	86.2	64.41	66.17
Operating Income	181.8	178.15	149.36	138.6	137.9
Interest Expense	-34.53	-34.57	-33.56	-17.62	-3.52
Interest & Investment Income	27.88	23.85	11.98	10.54	17.48
Earnings From Equity Investments	-	9	6.53	-	-
Other Non Operating Income (Expenses)	-16.76	-21.93	-8.73	-32	-18.7
EBT Excluding Unusual Items	158.39	154.51	125.58	99.52	133.17
Gain (Loss) on Sale of Assets	-	-3.29	0.2	-1.35	-4
Pretax Income	158.39	151.22	125.78	98.17	129.17
Net Income	158.39	151.22	125.78	98.17	129.17
Preferred Dividends & Other Adjustments	-	-	-	-	-21.57
Net Income to Common	158.39	151.22	125.78	98.17	150.74
Net Income Growth	4.74%	20.22%	28.13%	-24.00%	5.21%
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15
Shares Change (YoY)	-0.01%	-	-	-0.00%	0.00%
EPS (Basic)	10.61	10.13	8.42	6.58	10.10
EPS (Diluted)	10.61	10.13	8.42	6.58	10.10
EPS Growth	4.75%	20.22%	28.13%	-34.88%	22.79%
Free Cash Flow	204.55	237.02	209.59	231.83	239.82
Free Cash Flow Per Share	13.70	15.88	14.04	15.53	16.06
Dividend Per Share	-	7.700	6.420	8.022	8.650
Dividend Growth	-	19.94%	-19.97%	-7.26%	-
Gross Margin	80.70%	83.16%	83.09%	79.71%	76.75%
Operating Margin	48.26%	51.10%	52.68%	54.42%	51.86%
Profit Margin	42.04%	43.38%	44.37%	38.55%	56.69%
Free Cash Flow Margin	54.30%	67.99%	73.93%	91.03%	90.20%
EBITDA	190.66	187.01	157.64	142.41	142.04
EBITDA Margin	50.61%	53.64%	55.60%	55.92%	53.42%
D&A For EBITDA	8.86	8.86	8.28	3.81	4.14
EBIT	181.8	178.15	149.36	138.6	137.9
EBIT Margin	48.26%	51.10%	52.68%	54.42%	51.86%
Advertising Expenses	-	28.32	23.97	17.11	15.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.